Frontiers of Medicine

Papers
(The H4-Index of Frontiers of Medicine is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection1551
Coronavirus disease 2019 (COVID-19): a clinical update273
Oxidative stress and diabetes: antioxidative strategies234
Clinical characteristics of 19 neonates born to mothers with COVID-19178
Biological properties and clinical applications of berberine177
Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain169
COVID-19 containment: China provides important lessons for global response104
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-1995
Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-1988
Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions76
Deep learning in digital pathology image analysis: a survey74
Application of artificial intelligence in surgery70
Precision medicine in acute lymphoblastic leukemia69
Factors influencing peak bone mass gain65
Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies60
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial60
Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection54
The role played by traditional Chinese medicine in preventing and treating COVID-19 in China46
Adjuvant treatment strategy after curative resection for hepatocellular carcinoma45
Review of surgical robotic systems for keyhole and endoscopic procedures: state of the art and perspectives42
China’s local governments are combating COVID-19 with unprecedented responses — from a Wenzhou governance perspective39
Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis38
Decellularized extracellular matrix mediates tissue construction and regeneration38
Development of oncolytic virotherapy: from genetic modification to combination therapy38
Intratumor heterogeneity, microenvironment, and mechanisms of drug resistance in glioma recurrence and evolution37
SARS-CoV-2 variants, immune escape, and countermeasures37
Estimation of reproduction numbers of COVID-19 in typical countries and epidemic trends under different prevention and control scenarios37
Integrated analysis of gut microbiome and host immune responses in COVID-1936
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis35
Mechanism of insulin resistance in obesity: a role of ATP34
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases32
Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial32
0.039721012115479